✦ LIBER ✦

Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation

✍ Scribed by Philippe Armand; Haesook T. Kim; Daniel J. DeAngelo; Vincent T. Ho; Corey S. Cutler; Richard M. Stone; Jerome Ritz; Edwin P. Alyea; Joseph H. Antin; Robert J. Soiffer

Book ID: 116279638
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 306 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2007.01.079

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of AML and MDS relapsing after

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

✍ Oran, B; Giralt, S; Couriel, D; Hosing, C; Shpall, E J; de Meis, E; Khouri, I F; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Outcomes of patients with AML and MDS wh

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

✍ Pollyea, D A; Artz, A S; Stock, W; Daugherty, C; Godley, L; Odenike, O M; Rich, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Impact of Cytogenetics and Marrow Remiss

Impact of Cytogenetics and Marrow Remission Status on Disease Progression in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Stem Cell Transplantation

✍ E. Koca; R.M. Saliba; M. de Lima; U. Popat; P. Kebriaei; G. Rondon; W. Zhang; S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Azacitidine and donor lymphocyte infusio

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

✍ Schroeder, T; Czibere, A; Platzbecker, U; Bug, G; Uharek, L; Luft, T; Giagounidi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

P-213 Impact of individual cytogenetic a

P-213 Impact of individual cytogenetic abnormalities, IPSS-R karyotype and monosomal karyotype on outcomes after allogeneic HCT for MDS/sAML

✍ Kelaidi, C.; Sakellari, I.; Tzannou, I.; Liga, M.; Spyridonidis, A.; Tsirigotis, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Different impact of intermediate and unf

Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution

✍ H. Nahi, M. Remberger, M. Machaczka, J. Ungerstedt, J. Mattson, O. Ringden, Kata 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 453 KB